Dr. Supachai Parchariyanon, so-called Dr. Kid, is a CEO and Co-founder of RISE, a leading Corporate Innovation Powerhouse based out of Southeast Asia. He is also a Co-Founder and Managing Partner at SEA Exponential Fund (SeaX), the fund that invests globally in early-stage companies with game-changing technologies with exponential potential.
Dr. Kid is a serial entrepreneur who, at the age of 19, developed and sold the first mobile stock trading application for the Stock Exchange of Thailand (now #1 stock trading app in the country) in 2005. In 2011, he founded MCFIVA, a digital advertising agency that manages multi-million advertising campaigns for Fortune 500 companies in Thailand and Southeast Asia. In 2013, D2C Inc (Japan) - NTT Docomo Group of companies acquired a sizable stake in MCFIVA and invested into the company to expand into SEA.
In 2016, he founded RISE, Corporate Innovation Powerhouse that work closely with large conglomerates and governments in Southeast Asia with the bold mission to lift up 1 percent of GDP for Southeast Asia. RISE has been working closely with leading corporates and government agencies across the region to assist them to innovate faster through its unique corporate accelerator, intrapreneur university, venture building services, and experiential conference. Since day one, RISE has been creating the global ecosystem for corporate innovation with a network of 400+ corporations, 2,000 + startups, and innovation communities across the globe in 40+ countries, contributing to a combined valuation of over $1 billion within the past four years. In 2020, RISE announced that it has raised USD 8 million in its Seed Round, which is considered as one of the largest seed rounds in Southeast Asia.
Dr. Kid holds MS in Biomedical Informatics from Oregon Health and Science University and MD from Mahidol University. He is also the former President of Digital Advertising Association Thailand, Stanford's Graduate School of Business Alumni and fellow and member of a number of professional associations in the US and Asia.
